JP2019193662A5 - - Google Patents

Download PDF

Info

Publication number
JP2019193662A5
JP2019193662A5 JP2019129161A JP2019129161A JP2019193662A5 JP 2019193662 A5 JP2019193662 A5 JP 2019193662A5 JP 2019129161 A JP2019129161 A JP 2019129161A JP 2019129161 A JP2019129161 A JP 2019129161A JP 2019193662 A5 JP2019193662 A5 JP 2019193662A5
Authority
JP
Japan
Prior art keywords
cancer
newcastle disease
disease virus
attenuated newcastle
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019129161A
Other languages
English (en)
Japanese (ja)
Other versions
JP6862500B2 (ja
JP2019193662A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019193662A publication Critical patent/JP2019193662A/ja
Publication of JP2019193662A5 publication Critical patent/JP2019193662A5/ja
Application granted granted Critical
Publication of JP6862500B2 publication Critical patent/JP6862500B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019129161A 2013-09-03 2019-07-11 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法 Expired - Fee Related JP6862500B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361873039P 2013-09-03 2013-09-03
US61/873,039 2013-09-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016537333A Division JP6557234B2 (ja) 2013-09-03 2014-09-02 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法

Publications (3)

Publication Number Publication Date
JP2019193662A JP2019193662A (ja) 2019-11-07
JP2019193662A5 true JP2019193662A5 (https=) 2020-02-27
JP6862500B2 JP6862500B2 (ja) 2021-04-21

Family

ID=51492938

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016537333A Expired - Fee Related JP6557234B2 (ja) 2013-09-03 2014-09-02 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法
JP2019129161A Expired - Fee Related JP6862500B2 (ja) 2013-09-03 2019-07-11 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016537333A Expired - Fee Related JP6557234B2 (ja) 2013-09-03 2014-09-02 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法

Country Status (25)

Country Link
US (2) US10519426B2 (https=)
EP (3) EP3041490B1 (https=)
JP (2) JP6557234B2 (https=)
KR (2) KR102285894B1 (https=)
CN (2) CN111944767A (https=)
AU (2) AU2014317215C1 (https=)
CA (1) CA2922071C (https=)
CY (2) CY1121993T1 (https=)
DK (2) DK3041490T3 (https=)
EA (2) EA202191926A3 (https=)
ES (2) ES2914577T3 (https=)
HK (1) HK1231393A1 (https=)
HR (2) HRP20220653T1 (https=)
HU (1) HUE042382T2 (https=)
LT (2) LT3508209T (https=)
ME (1) ME03345B (https=)
MX (2) MX367768B (https=)
PL (2) PL3508209T3 (https=)
PT (2) PT3508209T (https=)
RS (2) RS63291B1 (https=)
SI (2) SI3041490T1 (https=)
SM (2) SMT201900094T1 (https=)
TR (1) TR201902073T4 (https=)
TW (1) TWI653334B (https=)
WO (1) WO2015032755A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2251034T3 (pl) 2005-12-02 2018-07-31 Icahn School Of Medicine At Mount Sinai Chimeryczne wirusy prezentujące nienatywne białka powierzchniowe i zastosowania tych wirusów
EP2987856B1 (en) 2009-02-05 2018-07-25 Icahn School of Medicine at Mount Sinai Chimeric newcastle disease viruses and uses thereof
EP2968525A4 (en) 2013-03-14 2016-10-26 Icahn School Med Mount Sinai MORBUS NEWCASTLE VIRUSES AND USES THEREOF
HUE042382T2 (hu) * 2013-09-03 2019-06-28 Medimmune Ltd Legyengített Newcastle betegség vírust tartalmazó készítmények és azok alkalmazása neoplázia kezelési eljárásában történõ alkalmazásra
EP3110443A4 (en) 2014-02-27 2017-11-15 Viralytics Limited Combination method for treatment of cancer
CN107847610B (zh) * 2015-04-28 2022-02-01 塞维卡有限责任公司 基于piv5的扩增病毒样颗粒
US10612005B2 (en) 2016-01-08 2020-04-07 Replimune Limited Modified oncolytic virus
EP3246410A1 (en) 2016-05-19 2017-11-22 Klinikum rechts der Isar der Technischen Universität München Vsv/ndv hybrid viruses for oncolytic therapy of cancer
GB201700350D0 (en) 2017-01-09 2017-02-22 Replimune Ltd Altered virus
KR101964610B1 (ko) * 2017-03-13 2019-04-03 대한민국 신규한 종양용해성 바이러스 및 이의 용도
JOP20190256A1 (ar) 2017-05-12 2019-10-28 Icahn School Med Mount Sinai فيروسات داء نيوكاسل واستخداماتها
CN107254450A (zh) * 2017-07-20 2017-10-17 扬州大学 克服鸡新城疫母源抗体影响的嵌合新城疫病毒疫苗载体候选株及构建方法
CN108486279A (zh) * 2017-09-21 2018-09-04 山东省农业科学院家禽研究所 一种基于荧光定量pcr技术检测鸽新城疫病毒的方法
EP3552608A1 (en) * 2018-04-09 2019-10-16 Rapo Yerape B.H. Ltd Increased activity of oncoloytic newcastle disease virus
CN112739359A (zh) * 2018-07-13 2021-04-30 西奈山伊坎医学院 Apmv及其用于治疗癌症的用途
WO2020037215A1 (en) 2018-08-17 2020-02-20 Icahn School Of Medicine At Mount Sinai Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease
CN110859968A (zh) * 2019-11-21 2020-03-06 四川安可康生物医药有限公司 激活对肿瘤的系统免疫反应的基因生物药物
JP7851254B2 (ja) * 2020-03-20 2026-04-24 オルナ セラピューティクス インコーポレイテッド 環状rna組成物及び方法
WO2021229270A1 (es) 2020-05-13 2021-11-18 Laboratorio Avi-Mex, S.A. De C.V. Vacuna recombinante contra covid-19 en vector viral
CN115197949A (zh) * 2021-04-13 2022-10-18 江苏康缘瑞翱生物医药科技有限公司 一种重组新城疫病毒rNDV-OX40L、其基因组、制备方法及其用途
US20220396809A1 (en) * 2021-06-03 2022-12-15 University Of Guelph Engineered newcastle disease virus vector and uses thereof
CN121263205A (zh) * 2023-02-06 2026-01-02 塞维卡有限责任公司 修饰的piv5疫苗载体:制造方法和用途
WO2025116613A1 (ko) * 2023-11-29 2025-06-05 주식회사 카브 재조합 뉴캣슬병 바이러스 벡터를 포함하는 암 치료용 약제학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7724558B1 (en) * 1999-03-19 2010-05-25 Nec Corporation Magnetic signal transmission line
ATE451835T1 (de) * 1999-09-24 2010-01-15 Mayo Foundation Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae
KR100801180B1 (ko) * 2006-09-26 2008-02-05 주식회사 고려비엔피 약독화된 재조합 뉴캐슬병 바이러스 및 이를 함유하는뉴캐슬병 백신
EP2085092A1 (en) * 2008-01-29 2009-08-05 Bayer Schering Pharma Aktiengesellschaft Attenuated oncolytic paramyxoviruses encoding avian cytokines
US20090208495A1 (en) 2008-02-14 2009-08-20 Bayer Schering Pharma Ag Anti-tumor effective paramyxovirus
EP2987856B1 (en) * 2009-02-05 2018-07-25 Icahn School of Medicine at Mount Sinai Chimeric newcastle disease viruses and uses thereof
EP2968525A4 (en) * 2013-03-14 2016-10-26 Icahn School Med Mount Sinai MORBUS NEWCASTLE VIRUSES AND USES THEREOF
HUE042382T2 (hu) * 2013-09-03 2019-06-28 Medimmune Ltd Legyengített Newcastle betegség vírust tartalmazó készítmények és azok alkalmazása neoplázia kezelési eljárásában történõ alkalmazásra
CN109099045A (zh) * 2018-10-30 2018-12-28 浙江斯泰新材料科技股份有限公司 防松锁固型螺钉

Similar Documents

Publication Publication Date Title
JP2019193662A5 (https=)
JP2016533749A5 (https=)
JP2023519173A5 (https=)
HRP20220653T1 (hr) Sastavi koji sadrže oslabljeni virus newcastleske bolesti i postupci uporabe za liječenje neoplazije
CN106795527B (zh) 溶瘤病毒
JP2014506913A5 (https=)
JP2019508403A5 (https=)
CN110603048A (zh) 细胞因子组合
WO2017209053A1 (ja) 新規な遺伝子組換えワクシニアウイルス
JP2016531927A5 (https=)
HRP20191972T1 (hr) Pripravci i postupci za aktiviranje signalizacije ovisne o "stimulatoru gena interferona"
JP2018512150A5 (https=)
JP2015506179A5 (https=)
JP2019533015A5 (https=)
JP2014207903A5 (https=)
RU2017134519A (ru) Терапевтические композиции и способы применения для лечения рака
KR20100122482A (ko) 항종양 효과가 있는 파라믹소바이러스
JP2012162567A5 (https=)
JP2019038797A5 (https=)
JP2020528890A (ja) 腫瘍を治療するためのウイルス
Zinovieva et al. Oncolytic vesicular stomatitis virus: optimisation strategies for Anti-Cancer therapies
JP2017522326A5 (https=)
Chen et al. Oncolytic Virotherapy in Solid Tumors: A Current Review: C. Chen et al.
JP2018537433A5 (https=)
Lundstrom Latest trends in cancer therapy applying viral vectors